Prevent Cancer Foundation welcomes largest-ever Corporate Membership Program cohort in 2026

The Prevent Cancer Foundation's logo, which has a green double helix to the left of the words, "Prevent Cancer Foundation."

POUR DIFFUSION IMMÉDIATE

Kyra Meister
703-836-1746
kyra.meister@preventcancer.org

Alexandria, Virginie – La Fondation Prevent Cancer® is proud to welcome 23 leading companies to its Corporate Membership Program. Together, they make up the program’s largest-ever cohort, strengthening a growing network of business leaders dedicated to reducing the impact of cancer through prevention and early detection.

Program members receive exclusive access to Foundation events and resources while providing vital support for the Foundation’s work in education, outreach, advocacy and community. Through collaboration and the exchange of ideas, members help advance cancer prevention and early detection efforts, empowering people to take steps that can improve health outcomes and save more lives.

“Our corporate partners play a vital role in advancing cancer prevention and early detection nationwide,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We’re proud to work alongside companies that share our vision of a world where cancer is preventable, detectable and beatable for all.”

The 2026 class of corporate members, as of the date of this publication, include:

Silver members

  • Abbott
  • Bristol Myers Squibb
  • Hologique
  • Pfizer
  • PhRMA

Bronze members

  • AbbVie
  • Astellas
  • AstraZeneca
  • Boehringer Ingelheim
  • Eisaï
  • Eli Lilly & Co
  • Exelixis
  • Freenome
  • Genentech
  • Geneoscopy
  • GSK
  • Gardien de la santé
  • Merck
  • Mercy BioAnalytics
  • Natera
  • Novartis
  • Sanofi

The Corporate Membership Program is open to companies who support the Foundation’s mission: Stopping Cancer. Saving Lives. To learn more or inquire about joining, contact Anne Potter, Senior Director of Corporate and Foundation Relations, at anne.potter@prevencancer.org.

###

À propos de la Fondation Prévenir le Cancer® 

La Fondation Prévenir le Cancer® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, advocacy and community, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.

La Fondation se mobilise pour relever le défi de réduire les décès par cancer de 40% d'ici 2035. Pour y parvenir, nous nous engageons à investir $20 millions dans des technologies innovantes pour détecter le cancer à un stade précoce et faire progresser le dépistage multi-cancer, $10 millions pour étendre le dépistage du cancer et la vaccination. l'accès à des communautés médicalement mal desservies et $10 millions pour informer le public sur les options de dépistage et de vaccination.

Pour plus d'informations, s'il vous plaît visitez www.preventcancer.org.